Retatrutide
Retatrutide-30mg
Synthetic peptide with a glucagon-derived structure, studied as an agonist of the GLP-1, GIP and glucagon receptors. An investigational compound with no marketing authorisation in the European Union. Supplied lyophilised in a sealed vial, with a technical sheet and storage instructions.
120 €Order
Specifications
| CAS | 2381089-83-2 |
|---|---|
| Formula | C₂₂₁H₃₄₂N₄₆O₆₈ |
| Molar mass | 4731,34 g/mol |
| Purity | Over 98% |
| Form | Lyophilised |
| Quantity | 30mg |
| Origin | Germany |
| Storage | 2–8 °C, protected from light |
| Current lot | AL-2609 |
The compounds in this catalogue are intended for laboratory research only. They are not medicines, are not authorised for administration to humans or animals, and are supplied without dosage or therapeutic use instructions. Aether Labs does not provide medical advice and ships only to registered entities.